Volume: 3, Issue: 1
ABSTRACT
Rare ocular diseases present a significant challenge within the public health landscape. Unlike common eye disorders such as near and farsightedness, cataracts, and macular degeneration, these rare maladies are characterised by diagnostic hurdles and dearth of established protocols for treatment. However, the ophthalmologists are uniquely prepared to investigate the multifaceted impact of rare eye diseases in addressing the unmet medical need (1)